IP Verse

Treatment Of Phenylketonuria With Bh4 - EP3138566B1

PatentPatent Analysis

EP3138566

BIOMARIN PHARMACEUTICAL
Application Number
EP16178739A
Filing Date
Nov 17, 2004
Status
Revoked
Jun 7, 2024
Grant Date
Jan 26, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3328416B1
EP3461503B9
EP3175863B1

Bibliography

The patent EP3138566B1 was granted to Biomarin Pharmaceutical on Jan 26, 2022 following the initial filing on Nov 17, 2004 under the application number EP16178739A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DIPHARMAOct 26, 2022WITHDRAWN
TOBIO NOVELFARMA ILAC SAN VE TICOct 12, 2022ADMISSIBLE
STADA ARZNEIMITTELOct 6, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents